Concepedia

Chandler Park

CP

3

Publications

73

Citations

3

H-Index

2014

Active since

Affiliations

Moffitt Cancer Center(Current)

Chandler Park is an author at Moffitt Cancer Center specializing in medicine, tumor microenvironment, and tumor biology.

Top concepts

MedicineOncologyPharmacologyTumor BiologyCancer TherapyThyroid CancerCancer ResearchPharmacotherapyThyroid DisordersRadiation Oncology

Publications per year

2014–2024

3

Publications

3

Sorafenib and thyroid cancer

Chandler Park, Jessica Perini, Roger W. Farmer et al. · Expert Review of Endocrinology & Metabolism · 2014 · 37 citations

Tumor Biology, Medicine, Thyroid Disease +12

TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy

Daniel P. Petrylak, Scott T. Tagawa, Rohit Jain et al. · Journal of Clinical Oncology · 2024 · 19 citations · Full text

Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Alexandra Drakaki, Thomas Powles, Aristotelis Bamias et al. · Clinical Cancer Research · 2023 · 17 citations

Rows per page

1–3 of 3